COMP <GO>
EFOR vs AMN // NET PROFIT MARGIN
Everforth Inc. (NYSE) VS. AMN Healthcare Services Inc (NYSE) • 15-METRIC TALLY: EFOR 7
— AMN 3
▲ NET PROFIT MARGIN LEADER: EFOR
LAST: $37.50 (-1.78%) • MKT CAP: $1.57B
net-margins
2.90%
LAST: $45.77 (-2.84%) • MKT CAP: $1.82B
net-margins
-3.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EFOR VS. AMN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EFOR | AMN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.90% | 28.30% | +0.60 | EFOR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.50% | -7.20% | +13.70 | EFOR | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.6x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 18.99% | 12.86% | +6.13 | EFOR | /fcf-yield <GO> |
| Operating Margin | 5.80% | -2.00% | +7.80 | EFOR | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 2.90% | -3.50% | +6.40 | EFOR | /net-margins <GO> |
| Revenue Growth (YoY) | -2.90% | -8.50% | +5.60 | EFOR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.35 | 2.76 | -0.41 | AMN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | EFOR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.4 | 75.2 | -22.80 | AMN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 12.5x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.57B | $1.82B | -$259.2M | AMN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EFOR REV | AMN REV | EFOR GROSS % | AMN GROSS % | EFOR FCF | AMN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.98B | $2.73B | 28.9% | 28.3% | $288.1M | $233.8M |
| FY 2024 | $4.10B | $2.98B | 28.9% | 30.8% | $364.7M | $239.5M |
| FY 2023 | $4.45B | $3.79B | — | — | $456.9M | $372.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EFOR // BETA —
AMN // BETA —